![]() ![]() ![]() Results: The study ultimately included 2220 patients, with a median follow-up of 8 years and 454 (20.5%) deaths until the end of follow-up. The predictive ability of different risk scores for long-term prognosis was compared according to the receiver operating characteristic (ROC) area under the curve (AUC), and the ability to distinguish patients with different risk levels was compared according to Kaplan−Meier survival curves. All-cause death and time of death of patients were confirmed by telephone follow-up, electronic medical record query, and household registration information. The long-term follow-up of patients was conducted until the end of January 2021. The patients were scored by GRACE score, TIMI score, and HEART score. Methods: The hospitalization data of patients who were hospitalized in West China Hospital of Sichuan University from 2011 to 2013 and diagnosed with acute myocardial infarction (AMI) were collected. The TIMI risk score is a simple prognostication scheme that categorizes a patient's risk of death and ischemic events and provides a basis for therapeutic decision making.Background and aims: To compare the value of three commonly used cardiovascular short-term risk scoring models, the GRACE score, TIMI score, and HEART score, in predicting the long-term prognosis of patients with acute myocardial infarction. The event rates was significantly lower in the enoxaparin groups in both TIMI 11B (P =.01) and ESSENCE (P =.03).The pattern of increasing event rates with increasing TIMI risk score was confirmed in all 3 validation groups (P2% for a score of 3, 19.9% for a score of 4, 26.2% for a score of 5, 40.9% for a score of 6/7. Event rates increased as the TIMI risk score increased 4.7% for a score of 0/1, 8.3% for a score of 2, 13.The 7 TIMI risk score predictor variables were: age ≥ 65, at least 3 risk factors for CAD, prior coronary stenosis of ≥50%, ST-segment deviation on ECG at presentation, at least 2 anginal events in prior 24 hours, use of aspirin in prior 7 days, and elevated serum cardiac markers.To develop a simple risk score that has broad applicability, is easily calculated at patient presentation, does not require a computer, and identifies patients with different responses to treatments for UA/NSTEMI. N = 15 were assigned respectively in ESSENCE trial.N = 1957 patients with UA/NSTEMI were assigned to receive unfractionated heparin (test cohort) and 1953 to receive enoxaparin in TIMI 11B trial.Patients and give this a Class IA, Level of Evidence A recommendationĪnalysis of two Phase 3, International, Randomized, Double-Blind trials (TIMI 11B and ESSENCE) This highlights the importance of further admission and testing, or veryįor NSTEMI say that risk scores should be used to assess the prognosis in Risk within the first 14 days of presentation. Risk scores also had better outcomes if treated with enoxaparin versusĮven patients with the lowest TIMI risk score (0 - 1) are still at concerning In event rates with higher TIMI risk scores Their risk for cardiac related ischemic events and death within the first 14 Easy bedside calculation mostly based on the patient's medical history and aįew initial tests (ECG and initial labs) in patients presenting to theĮmergency department (ED) with unstable angina or NSTEMI when trying to assess
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |